TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,398,734 | -1.5% | 13,794,359 | +0.0% | 0.06% | +1.7% |
| Q2 2023 | $216,606,982 | -3.2% | 13,787,841 | +1.5% | 0.06% | -9.4% |
| Q1 2023 | $223,789,501 | +436.1% | 13,579,460 | +407.4% | 0.06% | +392.3% |
| Q4 2022 | $41,747,737 | +3408.2% | 2,676,137 | +3990.1% | 0.01% | – |
| Q4 2020 | $1,190,000 | +18.5% | 65,430 | +18.2% | 0.00% | – |
| Q3 2020 | $1,004,000 | +8.0% | 55,375 | +7.9% | 0.00% | – |
| Q2 2020 | $930,000 | +67.0% | 51,333 | +43.9% | 0.00% | – |
| Q1 2020 | $557,000 | +13.2% | 35,661 | +42.4% | 0.00% | – |
| Q4 2019 | $492,000 | +45.1% | 25,046 | +28.1% | 0.00% | – |
| Q3 2019 | $339,000 | – | 19,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |